Dominik Selleslag Selected Research

Transplantation

3/2024	Epidemiological characteristics and outcome of viral respiratory tract infections in the first year after allogeneic hematopoietic cell transplantation.
2/2023	Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay.
1/2017	Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.
11/2006	Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
12/2004	Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominik Selleslag Research Topics

Disease

24	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 04/2004
23	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 04/2004
12	Neoplasms (Cancer) 01/2023 - 05/2011
8	Infections 01/2023 - 01/2006
7	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 11/2010
6	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023 - 11/2006
6	Fatigue 12/2021 - 02/2013
6	Leukemia 07/2021 - 05/2011
6	Hemorrhage 01/2021 - 11/2010
5	Aspergillosis 01/2023 - 12/2004
5	Neutropenia 01/2023 - 01/2006
4	Primary Myelofibrosis (Myelosclerosis) 12/2022 - 10/2007
4	Pathologic Complete Response 12/2020 - 10/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 07/2021
3	Fever (Fevers) 01/2023 - 08/2015
3	Thrombocytopenia (Thrombopenia) 01/2023 - 03/2016
3	Multiple Sclerosis 06/2018 - 01/2018
2	Diarrhea 02/2023 - 01/2020
2	Mycoses (Diseases, Fungus) 01/2023 - 11/2018
2	Cytopenia 01/2023 - 11/2022
2	Splenomegaly 12/2022 - 05/2018
2	Crohn Disease (Crohn's Disease) 10/2021 - 04/2012
2	Febrile Neutropenia 01/2018 - 05/2011
2	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 12/2004
2	Multiple Myeloma 11/2012 - 02/2012
2	Iron Overload 09/2011 - 06/2011
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2024
1	Viral Pneumonia 03/2024
1	Opportunistic Infections (Opportunistic Infection) 12/2022
1	Hematologic Diseases (Blood Diseases) 12/2021
1	Ulcerative Colitis 10/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2021
1	Philadelphia Chromosome 07/2021
1	Nausea 01/2020
1	Anemia 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Asthenia 01/2020
1	Dizziness (Lightheadedness) 01/2020
1	Residual Neoplasm 01/2019
1	Relapsing-Remitting Multiple Sclerosis 03/2018
1	Myocardial Infarction 01/2018
1	Pain (Aches) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Retinal Vein Occlusion 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Vomiting 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018

Drug/Important Bio-Agent (IBA)

9	Azacitidine (5 Azacytidine)FDA Link 10/2023 - 07/2015
5	romiplostim FDA Link 01/2021 - 11/2010
5	Inosine Triphosphate (ITP)IBA 01/2021 - 02/2015
5	Lenalidomide (CC 5013)FDA Link 01/2018 - 10/2011
5	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2015 - 04/2004
4	ruxolitinibIBA 12/2022 - 08/2012
3	Clofarabine (Clolar)FDA Link 05/2024 - 01/2017
3	Caspofungin (Cancidas)FDA Link 01/2023 - 12/2004
3	Voriconazole (Vfend)FDA LinkGeneric 01/2018 - 01/2006
3	Gemtuzumab (Mylotarg)FDA Link 03/2016 - 12/2013
3	Decitabine FDA Link 01/2016 - 05/2011
3	IronIBA 05/2014 - 06/2011
2	23-valent pneumococcal capsular polysaccharide vaccineIBA 10/2023 - 08/2015
2	galactomannanIBA 01/2023 - 07/2005
2	eltrombopag FDA Link 01/2023 - 01/2018
2	HematinicsIBA 12/2022 - 01/2020
2	SteroidsIBA 10/2021 - 04/2018
2	cc-486IBA 12/2020 - 02/2016
2	Alemtuzumab (Campath)FDA Link 03/2018 - 01/2018
2	isavuconazoleIBA 01/2018 - 02/2016
2	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2015 - 10/2005
2	Proteins (Proteins, Gene)FDA Link 06/2014 - 08/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2012 - 04/2004
2	fludarabineIBA 02/2012 - 04/2004
1	TriazolesIBA 01/2023
1	ANC 1IBA 01/2023
1	AzolesIBA 01/2023
1	Prostaglandins FIBA 01/2023
1	letermovirIBA 01/2023
1	Fluconazole (Zonal)FDA LinkGeneric 01/2023
1	Erythropoietin FDA Link 12/2022
1	venetoclaxIBA 11/2022
1	Antiviral Agents (Antivirals)IBA 10/2022
1	NucleosidesIBA 01/2022
1	vedolizumabIBA 10/2021
1	ponatinibIBA 07/2021
1	luspaterceptIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Sodium Glutamate (Accent)IBA 11/2018
1	Monoclonal AntibodiesIBA 03/2018
1	Thrombopoietin ReceptorsIBA 01/2018

Therapy/Procedure

14	Therapeutics 01/2023 - 12/2004
13	Drug Therapy (Chemotherapy) 10/2023 - 04/2004
10	Hematopoietic Stem Cell Transplantation 12/2022 - 11/2006
5	Cell Transplantation 03/2024 - 02/2013
5	Transplantation 03/2024 - 12/2004
5	Stem Cell Transplantation 01/2022 - 01/2006
2	Induction Chemotherapy 12/2020 - 10/2005
2	Self Administration (Administration, Self) 01/2020 - 02/2015
2	Remission Induction 01/2017 - 12/2015
2	Chelation Therapy (Therapy, Chelation) 05/2014 - 06/2011
1	Drug Tapering 12/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2018